These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32517876)

  • 1. A prospective analysis of micronutrient status in quiescent inflammatory bowel disease.
    MacMaster MJ; Damianopoulou S; Thomson C; Talwar D; Stefanowicz F; Catchpole A; Gerasimidis K; Gaya DR
    Clin Nutr; 2021 Jan; 40(1):327-331. PubMed ID: 32517876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrient Deficiencies in Children With Inflammatory Bowel Diseases.
    Ehrlich S; Mark AG; Rinawi F; Shamir R; Assa A
    Nutr Clin Pract; 2020 Apr; 35(2):315-322. PubMed ID: 31342601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronutrient deficiencies in inflammatory bowel disease.
    Weisshof R; Chermesh I
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):576-81. PubMed ID: 26418823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease.
    Rempel J; Grover K; El-Matary W
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis.
    Kamel AY; Johnson ZD; Hernandez I; Nguyen C; Rolfe M; Joseph T; Dixit D; Shen S; Chaudhry N; Pham A; Rampertab SD; Zimmermann E
    Eur J Gastroenterol Hepatol; 2024 Oct; 36(10):1186-1192. PubMed ID: 39012640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain.
    Isa HM; Alahmed FA; Mohamed M; Mohamed A
    Cureus; 2023 Apr; 15(4):e37074. PubMed ID: 37143618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Brownson E; Saunders J; Jatkowska A; White B; Gerasimidis K; Seenan JP; Macdonald J
    Inflamm Bowel Dis; 2024 Aug; 30(8):1233-1240. PubMed ID: 37611079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
    Nunes T; Etchevers MJ; Sandi MJ; Pinó Donnay S; Grandjean T; Pellisé M; Panés J; Ricart E; Iovanna JL; Dagorn JC; Chamaillard M; Sans M
    PLoS One; 2014; 9(1):e84957. PubMed ID: 24416322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease.
    Han YM; Yoon H; Lim S; Sung MK; Shin CM; Park YS; Kim N; Lee DH; Kim JS
    Gut Liver; 2017 May; 11(3):363-369. PubMed ID: 28208007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Chicco F; Magrì S; Cingolani A; Paduano D; Pesenti M; Zara F; Tumbarello F; Urru E; Melis A; Casula L; Fantini MC; Usai P
    Inflamm Bowel Dis; 2021 Jan; 27(1):1-9. PubMed ID: 32440680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).
    Viganò C; Palermo A; Mulinacci G; Pirola L; Losco A; Meucci G; Saibeni S; Pastorelli L; Amato A; Gatti M; Cortelezzi C; Di Sabatino A; Morganti D; Boni F; Grasso G; Casella G; Casini V; Caprioli FA; Vecchi M; Bezzio C; Bergna I; Radaelli F; Mengoli C; Massironi S
    Inflamm Bowel Dis; 2024 Jul; 30(7):1112-1120. PubMed ID: 37536282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission.
    Diederen K; Hoekman DR; Leek A; Wolters VM; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Benninga MA; Kindermann A
    Aliment Pharmacol Ther; 2017 Apr; 45(7):951-960. PubMed ID: 28138990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy.
    Engström J; Lönnkvist M; Befrits R; Ljung T; Diaz-Tartera H; Holst M; Hellström PM
    Scand J Gastroenterol; 2019 Sep; 54(9):1081-1088. PubMed ID: 31499013
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
    Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.